FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Suraksha Diagnostic IPO and Vishal Mega Mart IPO.
Suraksha Diagnostic IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Vishal Mega Mart IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Suraksha Diagnostic IPO | Vishal Mega Mart IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | ICICI Securities Limited Nuvama Wealth Management Limited SBI Capital Markets Limited |
Kotak Mahindra Capital Company Limited ICICI Securities Limited Intensive Fiscal Services Private Limited Jefferies India Private Limited J.P. Morgan India Private Limited Morgan Stanley India Company Pvt Ltd |
Registrar | Kfin Technologies Limited | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL |
The total issue size of Suraksha Diagnostic IPO is up to ₹846.25 Cr whereas the issue size of the Vishal Mega Mart IPO is up to ₹8,000.00 Cr. The final issue price of Suraksha Diagnostic IPO is ₹441.00 per share and of Vishal Mega Mart IPO is .
Suraksha Diagnostic IPO | Vishal Mega Mart IPO | |
---|---|---|
Face Value | ₹2 per share | ₹10 per share |
Issue Price (Lower) | ₹420.00 per share | ₹74.00 per share |
Issue Price (Upper) | ₹441.00 per share | ₹78.00 per share |
Issue Price (Final) | ₹441.00 per share | |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 34 shares | 190 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | ||
OFS Issue Size | 1,91,89,330 shares | 1,02,56,41,025 shares |
OFS Issue Size (Amount) | up to ₹846.25 Cr | up to ₹8,000.00 Cr |
Issue Size Total | 1,91,89,330 shares | 1,02,56,41,025 shares |
Issue Size Total (Amount) | up to ₹846.25 Cr | up to ₹8,000.00 Cr |
Suraksha Diagnostic IPO opens on Nov 29, 2024, while Vishal Mega Mart IPO opens on Dec 11, 2024. The closing date of Suraksha Diagnostic IPO and Vishal Mega Mart IPO is Dec 03, 2024, and Dec 13, 2024, respectively.
Suraksha Diagnostic IPO | Vishal Mega Mart IPO | |
---|---|---|
Anchor Bid Date | Nov 28, 2024 | Dec 10, 2024 |
Issue Open | Nov 29, 2024 | Dec 11, 2024 |
Issue Close | Dec 03, 2024 | Dec 13, 2024 |
Basis Of Allotment (Tentative) | Dec 04, 2024 | Dec 16, 2024 |
Initiation of Refunds (Tentative) | Dec 05, 2024 | Dec 17, 2024 |
Credit of Share (Tentative) | Dec 05, 2024 | Dec 17, 2024 |
Listing date (Tentative) | Dec 06, 2024 | Dec 18, 2024 |
Anchor Lockin End date 1 | Jan 03, 2025 | Jan 15, 2025 |
Anchor Lockin End date 2 | Mar 04, 2025 | Mar 16, 2025 |
Suraksha Diagnostic IPO P/E ratio is 99.31, as compared to Vishal Mega Mart IPO P/E ratio of 76.13.
Suraksha Diagnostic IPO | Vishal Mega Mart IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Suraksha Diagnostic Limited Financial Information (Restated Consolidated)Suraksha Diagnostic Limited's revenue increased by 14.75% and profit after tax (PAT) rose by 281.32% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Vishal Mega Mart Limited Financial Information (Restated Consolidated)Vishal Mega Mart Limited's revenue increased by 17.41% and profit after tax (PAT) rose by 43.78% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 61.07% | 96.46% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 48.78% | 76.02% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 99.31 | 76.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹2296.76 Cr. | ₹35168.01 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 14.09%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 21.46%% | 68.76%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹4.44 | ₹1.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 14.09%% | 8.18%% |
In the Suraksha Diagnostic IPO retail investors (RII) are offered 67,16,266 shares while in Vishal Mega Mart IPO retail investors are offered 67,16,266 shares. Qualified institutional buyers (QIB) are offered 38,37,867 shares in Suraksha Diagnostic IPO and 20,51,28,206 shares in Vishal Mega Mart IPO.
Suraksha Diagnostic IPO | Vishal Mega Mart IPO | |
---|---|---|
Anchor Investor Reserveration | 57,56,797 shares | 30,76,92,307 shares |
Market Maker Reserveration | ||
QIB | 38,37,867 shares | 20,51,28,206 shares |
NII | 28,78,400 shares | 15,38,46,154 shares |
RII | 67,16,266 shares | 35,89,74,359 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 1,34,32,533 shares | 71,79,48,719 shares |
Suraksha Diagnostic IPO subscribed 1.27x in total, whereas Vishal Mega Mart IPO subscribed 1.62x.
Suraksha Diagnostic IPO | Vishal Mega Mart IPO | |
---|---|---|
QIB (times) | 1.74x | 0.50x |
NII (times) | 1.40x | 4.05x |
Big NII (times) | 1.53x | 4.40x |
Small NII (times) | 1.16x | 3.35x |
RII (times) | 0.94x | 1.23x |
Employee (times) | ||
Other (times) | ||
Total (times) | 1.27x | 1.62x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|